approaching patients with pv after treatment failure
Published 4 days ago • 66 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
6:19
management of patients with pv who are intolerant to interferon and who develop post-polycythemic mf
-
1:20
approaching patients with mf who are ineligible for sct
-
1:15
unmet needs and emerging options for patients with pv
-
1:52
cytoreductive therapy for patients with pv
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
4:32
living with polycythemia vera
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
56:36
prophylactic tranexamic acid in preventing obstetric bleeding
-
1:22
real-world outcomes of patients with mf treated with fedratinib post-ruxolitinib discontinuation
-
3:29
current approaches and new approvals in mf and pv
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
3:07
the current treatment algorithm for polycythemia vera
-
1:25
the need for disease-modifying agents in pv to prevent disease progression
-
1:05
using machine learning to predict the outcomes of patients with ndmm being treated with vrd
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
2:38
ongoing data from the phase 3 response trial of ruxolitinib for polycythemia vera
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
0:46
prolonging survival in patients with aml ineligible for intensive chemotherapy
-
0:47
challenges in treating pv and optimal management strategies